BHF Kleinwort Benson Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$3.58M Hold
25,795
0.1% 130
2015
Q4
$3.6M Buy
25,795
+5,795
+29% +$798K 0.08% 167
2015
Q3
$2.8M Sell
20,000
-9,000
-31% -$1.35M 0.11% 113
2015
Q2
$4.76M Buy
+29,000
New +$4.63M 0.16% 155
2014
Q4
Sell
-25,900
Closed -$2.48M 475
2014
Q3
$2.48M Hold
25,900
0.08% 169
2014
Q2
$2.79M Hold
25,900
0.08% 164
2014
Q1
$2.58M Buy
+25,900
New +$2.34M 0.07% 187

Other funds holding ELV

BHF Kleinwort Benson Group's ELV Position: Q1 2016 in Review

BHF Kleinwort Benson Group held its Elevance Health (ELV) position steady in Q1 2016 at 25,795 shares worth $3.58M. The position accounts for 0.1% of the portfolio, ranked #130.

BHF Kleinwort Benson Group first reported a position in ELV in Q1 2014 and has held it in 7 quarters since. The position peaked at $4.76M in Q2 2015. 771 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

  • BHF Kleinwort Benson Group held 25,795 shares of Elevance Health worth $3.58M as of Q1 2016.
  • BHF Kleinwort Benson Group left its Elevance Health share count unchanged in Q1 2016.
  • Elevance Health made up 0.1% of BHF Kleinwort Benson Group's portfolio in Q1 2016, its #130 holding.
  • BHF Kleinwort Benson Group first reported a position in Elevance Health in Q1 2014 and has held it in 7 quarters since.
  • BHF Kleinwort Benson Group's Elevance Health position peaked at $4.76M in Q2 2015.
  • 771 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.